IFNG and colorectal carcinoma: Clay et al. identified inosine as a targetable microbial metabolite for 9potential therapeutic strategy for CRC antitumor immunity by looking at studies that correlated inosine with immune checkpoint inhibitors and the IFN-γ pathway (Figure 5) [121].